Company intelligence / Profile preview

Artisan Bio

Louisville / Denver area, Colorado, United Statesartisane-nyc.com ↗

Ownership: Private
Development stage: Other

Overview

Artisan Bio provides advanced genome engineering tools, including its proprietary STAR–CRISPR platform, to enable the rapid development of safer and more efficacious next-generation cell therapies. The company collaborates with both emerging biotechs and large pharmaceutical companies such as Takeda. Its technology is used in research programs targeting allogeneic cell therapies for immuno-oncology applications. Clinical results are driven by partner programs rather than internal assets.

Therapeutic areas: Oncology
Modalities: Cell therapyGene therapyCRISPR-based therapy
Industry: Non-Drug Biotech

Partnerships

Takeda (cell therapy research collaboration using genome editing technologies)

Beyond the preview

Go deeper on Artisan Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Artisan Bio.

Explore the full profile